Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

NCTID	NCT06289452 (View at clinicaltrials.gov)
Description	The goal of this clinical trial is to evaluate the safety and efficacy of IVB102 injection in subjects with XLRS. (Show More)
Development Status	Active
Indication	Retinoschisis, Retinal Disease, Retinal Degeneration, Eye Diseases
Disease Ontology Term	DOID:0060763
Compound Name	IVB102
Sponsor	InnoVec Biotherapeutics Inc.
Funder Type	Industry
Recruitment Status	Recruiting
Enrollment Count	18
Results Posted	Not Available

Target Gene/Variant	RS1
Therapy Type	Gene transfer
Therapy Route	In-vivo
Mechanism of Action	Functional gene replacement
Route of Administration	Intravitreal
Drug Product Type	Viral vector
Target Tissue/Cell
Delivery System	Viral transduction
Vector Type	AAV
Editor Type	none
Dose 1	Undisclosed low dose
Dose 2	Undisclosed medium dose
Dose 3	Undisclosed high dose
Dose 4
Dose 5

No.of Trial Sites	1
Locations	China

Has US IND	False
FDA Designations	Rare Pediatric Disease Designation
Recent Updates